风赛3安卓版本百度云

风赛3安卓版本百度云

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

风赛3安卓版本百度云

Learn More
Folded page of a newspaper

风赛3安卓版本百度云

风赛3安卓版本百度云

Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results

风赛3安卓版本百度云

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

风赛3安卓版本百度云

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

风赛3安卓版本百度云

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

风赛3安卓版本百度云

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

风赛3安卓版本百度云

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

安卓免费科学上外网 app  安卓机翻软件  橡树加速器  梯子飞机场搭建  苹果翻外墙软件免费  怏连VPN  雷光加速器  佛跳墙2.621下载